Holen Sie sich die Stockscreener-App
1.67
0.60%
-0.01
Handel nachbörslich:
1.70
0.03
+1.80%
Palisade Bio Inc Aktie (PALI) Neueste Nachrichten
Retail Trends: Will Palisade Bio Inc. stock benefit from sector rotation2025 Breakouts & Breakdowns & Stepwise Trade Signal Implementation - Улправда
Is Palisade Bio Inc. stock near bottom after decline2025 Trade Ideas & Smart Allocation Stock Tips - Улправда
Aug Final Week: Will Palisade Bio Inc. (7NS0) stock benefit from Fed rate cutsJuly 2025 Trade Ideas & Stepwise Trade Execution Plans - Улправда
How interest rate cuts could boost Palisade Bio Inc. stockTrade Risk Assessment & Capital Protection Trading Alerts - Улправда
How Palisade Bio Inc. stock reacts to bond yieldsPortfolio Profit Report & Free Risk Controlled Daily Trade Plans - Улправда
Why analysts remain bullish on Palisade Bio Inc. stockJuly 2025 Setups & Safe Entry Trade Signal Reports - Улправда
Aug Opening: How geopolitical risks impact Palisade Bio Inc. (7NS0) stockMarket Growth Summary & Low Drawdown Momentum Ideas - Улправда
Will Palisade Bio Inc. (7NS0) stock benefit from Fed rate cutsJuly 2025 Big Picture & High Conviction Investment Ideas - Улправда
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Palisade Bio Inc - GuruFocus
Palisade Bio approves key proposals at stockholder meeting - MSN
Palisade Bio Stock Soars as Clinical Workforce Expands with New VP Appointment - StocksToTrade
Palisade Bio Stock Surge: What’s Behind the Rise? - StocksToTrade
Palisade Bio’s Vice President Appointment and UC Trial Success Boost Confidence - timothysykes.com
Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, ENVB, BDRX, HSPO, BRZE Surge Ahead of Fed Decision - ts2.tech
Palisade Bio (NASDAQ:PALI) Trading Up 0.6%Here's What Happened - MarketBeat
Palisade Bio (NASDAQ:PALI) Trading Up 0.6% – Here’s What Happened - Defense World
How does Palisade Bio Inc (PALI) change from a tortoise to a hare? - setenews.com
Retail Surge: What earnings margins imply for Palisade Bio Inc 7NS0 stock2025 Macro Impact & AI Based Buy/Sell Signal Reports - moha.gov.vn
Palisade Bio prices 171.4M shares at 70c in upsized underwritten public offering - MSN
EBIT per share of Palisade Bio, Inc. – MUN:7NS0 - TradingView
Aug Mood: Is Palisade Bio Inc stock a good choice for value investorsJuly 2025 Outlook & Expert Verified Stock Movement Alerts - moha.gov.vn
Palisade Bio Inc. (PALI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Palisade Bio Inc. stock ready for breakoutQuarterly Portfolio Summary & Growth-Oriented Investment Plans - Newser
Palisade Bio increases authorized common shares following stockholder approval By Investing.com - Investing.com Nigeria
Palisade Bio increases authorized common shares following stockholder approval - Investing.com
Is Palisade Bio Inc. stock a buy before product launchesEarnings Beat & Weekly High Conviction Trade Ideas - Newser
How Palisade Bio Inc. (7NS0) stock correlates with oil markets2025 Top Decliners & Fast Gain Swing Trade Alerts - Newser
Will Palisade Bio Inc. stock beat EPS estimates2025 Fundamental Recap & Weekly Momentum Stock Picks - Newser
Will Palisade Bio Inc. (7NS0) stock profit from AI boomGlobal Markets & Reliable Intraday Trade Plans - Newser
Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec, MD, AGAF as Vice President, Clinical Development - markets.businessinsider.com
Palisade Bio appoints James Izanec as VP of clinical development By Investing.com - Investing.com Australia
PALI SEC FilingsPalisade Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Palisade Bio appoints James Izanec as VP of clinical development - Investing.com
Palisade Bio Appoints Dr. James Izanec as Vice President of Clinical Development - Quiver Quantitative
Palisade Bio strengthens clinical leadership team with appointment of James Izanec - marketscreener.com
Palisade Bio Strengthens Clinical Leadership Team with - GlobeNewswire
Can Palisade Bio Inc. stock weather global recession2025 Price Momentum & Short-Term Trading Alerts - Newser
Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec, MD, AGAF as Vice President, Clinical Development (2025-12-02) - Seeking Alpha
Will Palisade Bio Inc. (7NS0) stock announce special dividendJuly 2025 Short Interest & Capital Efficiency Focused Strategies - Newser
What is Palisade Bio Inc (PALI) Stock Return on Shareholders’ Capital? - setenews.com
How geopolitical risks impact Palisade Bio Inc. (7NS0) stockMarket Growth Report & Free Real-Time Volume Trigger Notifications - BỘ NỘI VỤ
Is Palisade Bio Inc. stock a good choice for value investorsMarket Trend Summary & Technical Buy Zone Confirmation - moha.gov.vn
What is the Price Targets for Palisade Bio Inc (PALI)? - fostersleader.com
Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewswire
The time has not yet come to remove your chips from the table: Palisade Bio Inc (PALI) - Setenews
What analysts say about Palisade Bio Inc stockStock Liquidity Analysis & Tap Into the Fastest-Growing Companies - earlytimes.in
How big funds are accumulating Palisade Bio Inc. (7NS0) stockJuly 2025 Pullbacks & High Accuracy Investment Signals - newser.com
How Palisade Bio Inc. stock performs after earnings2025 Short Interest & Intraday High Probability Setup Alerts - newser.com
Can Palisade Bio Inc. stock attract ESG capital inflowsWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - newser.com
Individual investors are Palisade Bio, Inc.'s (NASDAQ:PALI) biggest owners and were rewarded after market cap rose by US$70m last week - Yahoo Finance
Free cash flow per share of Palisade Bio, Inc. – FWB:7NS0 - TradingView
Using RSI to spot recovery in Palisade Bio Inc.2025 Analyst Calls & Daily Technical Forecast Reports - newser.com
Will Palisade Bio Inc. stock deliver consistent dividendsMarket Rally & Weekly High Return Opportunities - newser.com
0.31%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):